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Expanded GGGGCC (G4C2) nucleotide repeats
within the C9ORF72 gene are the most common ge-
netic mutation associated with both amyotrophic
lateral sclerosis (ALS) and frontotemporal dementia
(FTD). Sense and antisense transcripts of these ex-
pansions are translated to form five dipeptide repeat
proteins (DRPs). We employed primary cortical and
motor neuron cultures, live-cell imaging, and trans-
genic fly models and found that the arginine-rich
dipeptides, in particular Proline-Arginine (PR), are
potently neurotoxic. Factors that anticipated their
neurotoxicity included aggregation in nucleoli,
decreased number of processing bodies, and stress
granule formation, implying global translational dys-
regulation as path accountable for toxicity. Nuclear
PR aggregates were also found in human induced
motor neurons and postmortem spinal cord tissues
from C9ORF72 ALS and ALS/FTD patients. Intronic
G4C2 transcripts, but not loss of C9ORF72 protein,
are also toxic tomotor and cortical neurons. Interest-
ingly, G4C2 transcript-mediated neurotoxicity syner-
gizes with that of PR aggregates, suggesting conver-
gence of mechanisms.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS), a motor neuron degenera-
tive disease (Kiernan et al., 2011), and frontotemporal dementia
(FTD), a presenile onset dementia characterized by selective
degeneration of frontal and temporal lobes (Warren et al.,
2013), appear to be manifestations of the same clinicopatholog-
ical spectrum (Byrne et al., 2012; Elamin et al., 2013; PhukanNeet al., 2007, 2012). The recent identification of aberrant
GGGGCC (G4C2) intronic repeat expansions in the C9ORF72
gene (DeJesus-Hernandez et al., 2011; Renton et al., 2011) as
the most common cause for both ALS and FTD have further
emphasized this notion (Majounie et al., 2012). C9ORF72 pa-
tients carry from tens to hundreds of G4C2 repeats, while the
majority of unaffected individuals have no more than 2 to 25 re-
peats (Rutherford et al., 2012). Correlation between these
expanded repeats and severity of clinical manifestations has
yet to be established.
Repeat expansions in genes cause many hereditary diseases
in humans (La Spada and Taylor, 2010). The mechanisms by
which G4C2 repeat expansions cause neurodegeneration
are under intense investigation. Decreased C9ORF72 mRNA
expression levels were detected in C9-ALS/FTD patient lympho-
blasts (DeJesus-Hernandez et al., 2011). This led to the hypoth-
esis that the intronic expansions could cause downregulation of
the C9ORF72 protein, which could then be responsible for neu-
rodegeneration. Support for this loss-of-function hypothesis was
first reported in zebrafish (Ciura et al., 2013), although confirma-
tion is still lacking in mammalian models.
Lines of evidence supporting a gain-of-toxic-function hy-
pothesis of pathogenesis have recently started to emerge. For
instance, sense and antisense G4C2 repeat RNA transcripts
accumulate in nuclear foci in neurons of different CNS areas of
C9-ALS/FTD patients (Zu et al., 2013); antisense oligonucleo-
tides againstC9ORF72 transcripts reduced RNA-binding protein
sequestration and increased glutamate sensitivity of neurons
derived from induced pluripotent stem cells (iPSCs) of C9-ALS
patients (Donnelly et al., 2013); and G4C2 repeat expansions
adopt stable G-quadruplex motifs (Reddy et al., 2013), which
sequester ribonucleoproteins critical for cell survival (Haeusler
et al., 2014). Furthermore, repeat-associated, non-ATG initiated
(RAN) translation has been reported in several nucleotide repeat
disorders (Zu et al., 2011). RAN-translated proteins from sense
and antisense transcripts were reported accumulating in C9-
ALS/FTD tissues (Ash et al., 2013; Mori et al., 2013), implying auron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc. 1213
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translated proteins were recently described to cause toxicity
(Kwon et al., 2014; Mizielinska et al., 2014; Zhang et al., 2014).
All of the different and potentially toxic instances appear not to
be mutually exclusive, as evidence for their coexistence was
found in postmortem patient samples (Gendron et al., 2013a).
However, it remains challenging to tease out their individual con-
tributions and mechanisms of toxicity.
We were able to independently model these different
C9ORF72 pathogenic instances. By transfecting cortical and
motor neurons with constructs engineered by a randomized
codon strategy to express C9RAN proteins avoiding GC repeat
sequences, or constructs encoding intronic expanded G4C2 se-
quences that do not initiate RAN translation, and constructs that
efficiently knock down C9ORF72, we deciphered by means of
time-lapse live-cell imaging their respective impact on neuronal
viability. We also established transgenic Drosophila models of
C9RANproteins.We found that one of the antisense C9RANpro-
teins, the Proline-Arginine dipeptide (PR), is potently neurotoxic
when expressed in vivo and neurons with nuclear PR aggregates
have a much higher risk to undergo degeneration. In addition,
induced motor neurons (iMNs) derived from C9-ALS patients
showed intranuclear PR+ aggregates, increased number of
extracellular PR aggregates in the dish, and dramatic decrease
in survival compared to controls. Nuclear PR aggregates were
also found in human spinal cord tissues from C9ORF72 ALS/
FTD patients. Interestingly, we found that poly-PR peptides
aggregate in nucleoli, causing enlargement of the nucleolus,
cell stress responses, and ultimately cell death.
In PR-expressing neurons, death is preceded by a decreased
number of RNA-processing bodies (P-bodies) and by the
appearance of cytosolic stress granules. These findings suggest
that nuclear aggregation of PR peptides initiates a cascade of
events leading to neurodegeneration via global perturbation in
RNA processing and posttranscriptional regulation of gene
expression.
RESULTS
RAN Translated Poly-PR Proteins Are Neurotoxic
In vivo, pathogenic intronic G4C2 repeat expansions undergo
RAN translation on both sense and antisense transcripts using
all reading frames, giving rise to five dipeptide repeat proteins
(DRPs) of presumably variable length (antisense: poly-PR and
poly-PA; sense: poly-GA and poly-GR; both sense: poly-GP)
(Ash et al., 2013; Gendron et al., 2013b; Mori et al., 2013; Zu
et al., 2013). DRPs form aggregates in C9 patients in different
neurons, including those not affected by disease (Gendron
et al., 2013a; Zu et al., 2013). It remains an open question
whether and which DRPs initiate toxicity in neurons. To decipher
the neurotoxic profiles of the various DRPs, we transfected
mouse motor neuron-like NSC34 cells, as well as primary
cortical and motor neurons, with DRP-encoding constructs of
different lengths (25- to 400-dipeptide-long sequences) tagged
with GFP to aid identification of transfected cells. Constructs
were designed to express DRPs in an ATG-dependent transla-
tion and with a randomized codon strategy to ensure expression
of only the chosen DRP sequence at the desired length. This1214 Neuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Incapproach allowed us to engineer stable constructs containing
moderate GC content encoding up to 400-dipeptide-long re-
peats for GR and GA, 200 for PR and PA, and 50 for GP and to
avoid potential toxicity induced by G4C2 repeats expansion at
transcript level (Figure S1 available online).
Proper expression of DRP constructs in NCS34 cells was as-
sessed by western blot analysis using anti-DRPs (Ash et al.,
2013) (Figure S2A) and GFP antibodies. Notably, the arginine-
rich dipeptides, PR and GR, were consistently expressed at
somewhat lower levels, whereas expression levels of the other
DRPswere comparable (Figure S2B). Confocal microscopy anal-
ysis showed distinct PR and GR nuclear aggregates, whereas
GA- and PA-expressing cells revealed predominant cytoplas-
mic aggregates. Conversely, GP displayed diffused localization
(Figure S2C). The different DRPs had analogous localization pat-
terns when transfected in cortical and motor neurons (Figures
S2D and S2E).
We next sought to evaluate toxicity by longitudinal, live-cell
imaging that gauged survival of DRP-expressing neurons.
Mature cortical neurons (10 days in vitro [DIV10]) (Lesuisse and
Martin, 2002) were cotransfected with GFP-tagged DRP con-
structs and Td-Tomato reporter driven by the synapsin pro-
moter. This aided live visualization of transfected neurons
(Figures S3A, S3B, and S3C). The same GFP+ and Td-tomato+
cortical neurons were followed at 24 hr intervals, up to several
days posttransfection.
Expression of PR50 dramatically decreased cortical neuron
survival (Figure 1A), while the other four DRPs did not (Fig-
ure 1B). Most of PR50-mediated cell death occurred in the first
72 hr posttransfection. Interestingly, image analysis revealed
that the majority of neurons harboring PR nuclear aggregates
died within 24–48 hr after aggregates formed, while neurons
featuring diffused pattern of PR expression survived (Figure 1C).
This was confirmed by Kaplan-Meier survival and risk-of-death
analysis performed on cohorts of neurons displaying either
nuclear aggregates or diffused localization (Figure 1D). PR
neurotoxicity did not significantly vary with increased length
of repeats (Figure 1E), and the effect appeared to be concen-
tration dependent (Figure 1F). Clear length-dependent neuro-
toxicity was instead seen for poly-GR. Conversely, poly-PA,
GA, and GP were not significantly, or just marginally (poly-
PA), toxic at the longest lengths tested. Expression levels
were comparable among the DRPs of different lengths (Fig-
ure 1G). PR50 was also toxic to primary motor neurons. Howev-
er, these neurons were equally susceptible to expression of
GR50 (Figures S4A and S4B), which aggregated in the nucleus,
similarly to PR50 although less aggressively (Figures S2 and
S4B). Notably, hippocampal neurons, which are marginally
affected in C9-FTD (Warren et al., 2013), were also vulnerable
to PR toxicity, but to a much lesser extent than cortical neurons
and despite comparable expression levels, assessed as inten-
sity of GFP fluorescence signal (Figures S4C, S4D, and S4E).
Localization pattern of PR and extent of its toxicity did not
depend on the presence of the GFP tag in the dipeptide
sequence as the expression of untagged PR50 displayed similar
toxic and localization profile as the GFP-tagged dipeptide (Fig-
ures S4F, S4G, and S4H). In contrast to the toxic effect of PR50
on both cortical and motor neurons, we found that SOD1-G93A.
Figure 1. Neurotoxicity of C9RAN Poly-Di-
peptides
(A) Representative live-cell images of cortical
neurons cotransfected at DIV10 with control-
GFP + Td-tomato plasmids (4:1) or PR50-GFP +
Td-Tomato (4:1). The same neurons were
imaged for 9 days (8 days posttransfection) at
24 hr intervals. Calibration bar represents
100 mm.
(B) Kaplan-Meier survival analysis of cortical
neurons cotransfected with constructs encoding
different DRPs + Td-Tomato. At least 80 neurons
were followed/group; n = 5 experiments; ***p <
0.001. The insert shows the schematic of the
construct. The sequence of the insert is the
following: ATG-DYKDDK-KLGR-DPR50-GYRAR
IHYSSVVEFM-EGFP-TAA. The insert was subcl-
oned into pcDNA3.1 vector and its expression
driven by the CMV promoter. The DRP sequence
has been constructed with a randomized codon
strategy.
(C) PR50 aggregate formation preceded neuronal
death. Representative images show a group of
cortical neurons expressing both PR50 (GFP
tagged) and Td-tomato. Neurons in which PR50-
formed aggregates underwent cell death within
24–36 hr (yellow arrows, day 1–2; white arrows,
day 3–4) are shown. Conversely, neurons in which
PR50 stayed in a diffused, not aggregated, pattern
(orange arrow and insets) outlived the neurons
with PR aggregates. Calibration bar represents
50 mm.
(D) Cortical neurons transfected with PR50 that
formed aggregates exhibited decreased survival
and increased risk of death compared to those
that did not form detectable PR50 aggregates
(***p < 0.001). PR50-transfected neurons with no
detectable aggregates showed no difference in
survival and risk of death compared to control-
transfected neurons (p = 0.08).
(E) Length-dependent toxicity of DRPs in cortical
neurons. Poly-GR displayed clear length-depen-
dent toxicity (**p < 0.01; one-way ANOVA),
whereas the effect of poly-PR already peaked at
25 repeats, displaying no significant length de-
pendency (one-way ANOVA). Data are shown as
mean ± SEM.
(F) Cortical neuron toxicity of PR50 diminished as
amount of transfected cDNA was reduced,
suggesting a dose dependency in the effect. Maximum amount of cDNA-PR50 transfected was 0.8 mg/well (100%). Total amount of DNA transfected was kept
constant across groups (1 mg/well). *p < 0.05. Data are shown as mean ± SEM.
(G) NSC34 cells were transfected with indicated constructs. Expression levels of different lengths of DRP constructs were assessed using dot blots. Actin was
used as a loading control. Comparable expression levels were observed for DRPs of different lengths.
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and S4J). This observation is consistent with the fact that
the SOD1-G93A mutation causes pure ALS with no FTD
symptoms.
Neuronal Death by Intronic G4C2-Containing
Transcripts
It was recently shown that expanded G4C2 repeats are toxic to
neuronal cell lines and zebrafish embryos (Lee et al., 2013). A still
open question is whether G4C2 repeat expansions, harbored in
an intronic sequence, cause neurodegeneration independentlyNeof the C9ORF72 gene sequence. We generated plasmids con-
taining 0, 21, and 42 G4C2 repeats (R0, R21, R42) in an artificial
intronic sequence inserted between two EGFP exons (Figures
S5A and S5B) and transfected primary cortical neurons. These
neurons could be readily identified for live-cell imaging by the
concomitant Td-tomato and GFP fluorescence (Figure S5C).
GFP expression was confirmed by western blot analysis of ly-
sates of R0-R42-transfected NSC34 cells probed with an anti-
GFP antibody (Figure S5D). Expression of the G4C2 transcripts
was verified by fluorescence in situ hybridization (FISH) analysis
(Figure S5E), which revealed prevalent nuclear localization of theuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc. 1215
Figure 2. Intronic G4C2 Repeats Are
Directly Toxic to Primary Neurons
(A) Representative time-lapse images of cortical
neurons cotransfected with Td-Tomato and R0,
R21, or R42 constructs (1:4 ratio; 1 mg cDNA/well
total). Neurons that went on to die are pointed by
arrows. More death events were observed in
neurons transfected with R42. Calibration bar
represents 100 mm.
(B and C) Kaplan-Meier survival and cumulative
risk of death analysis of cortical neurons trans-
fected with R0, R21, or R42 showed that ex-
panded intronic G4C2 repeats caused cell death
and significantly increased the risk of death.
Neurotoxicity of G4C2 decreased with reduced
amount of R42 cDNA transfected into neurons,
suggesting dose dependency. Note that 50% of
R42 cDNA (or 0.4 mg) is not sufficient to cause
toxicity. Total amount DNA used in transfection
remained the same across groups. At least 80
neurons were followed/group; n = 3 experiments.
*p < 0.05, **p < 0.01, ***p < 0.001.
(D) Representative live-cell images based on GFP
fluorescence at day 1, 2, and 4 posttransfection of
R42 construct in motor neurons show clear motor
neuron loss. Calibration bar represents 50 mm.
(E) Risk-of-death analysis of motor neurons
transfected at DIV5 with R0-R42 constructs. At
least 40 motor neurons are imaged/group; n = 3
experiments. **p < 0.01.
(F) Kaplan-Meier survival analysis showed that
hippocampal neurons were not sensitive to
expanded intronic G4C2 repeats. At least 80 hip-
pocampal neurons were imaged/group; n = 3 ex-
periments. p = 0.337.
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R42 but not with R0.
Longitudinal live-cell imaging analysis showed that R42-trans-
fected cortical neurons survived significantly less than R0- or
R21-expressing neurons (Figure 2A). The risk of death increased
2-fold (Figure 2B). R42 construct displayed dose-dependent
toxicity with a threshold effect seen at 50% of the amount of
transfected cDNA (Figure 2C). R42-expressing motor neurons
had higher risk of death compared to R21 and controls (Figures
2D and 2E), whereas survival of hippocampal neurons was not
affected by the R42 transcript (Figure 2F).
G4C2 Repeats Neurotoxicity Is Independent on RAN
Translation
RNA sequence made of 38 G4C2 repeats can initiate RAN trans-
lation when expressed in HEK cells in a repeat length-dependent1216 Neuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc.manner (Mori et al., 2013). To determine
whether R42 neurotoxicity in our culture
systems was mediated by RAN transla-
tion, we performed western blot analysis
on lysates of R0-R42-transfected motor
neuron-like NSC34 cells using anti-
DRPs antibodies. We found no evidence
for formation of any of the five possible
DRPs (Figure 3A). This was furtherconfirmed in cortical neurons transfected with R42 by immuno-
cytochemistry and dot blot analysis (Figures 3B and 3C). While
intronic R42 repeats do not produce detectable DRPs, we found
that the concomitant expression of a subtoxic concentration of
R42 repeat transcripts (50% of the dose normally used) greatly
enhanced the damaging effect of a marginally toxic concentra-
tion (50% of the dose) of PR50 on cortical neurons (Figure 4A).
On the other hand, the prevalently cytosolic expression of GA
aggregates in combination with R42 did not produce the same
synergistic effect (Figure 4B).
Recently, nucleolar stress was proposed as a potentially toxic
mechanism of the G-quadruplexes formed by G4C2 transcripts
(Haeusler et al., 2014). Interestingly, PR aggregates colocalized
with nucleolin, a constituent protein of nucleolus. PR-containing
nucleoli appeared larger in size with dispersal of nucleolin stain-
ing, suggesting PR-mediated dynamic nucleolar stress response
Figure 3. DRPs Were Not Detected in Cells
Transfected with R42 Repeat Transcript
(A) NSC34 cells were transfected with the indi-
cated constructs. Efficiency of transfection is
90% for all groups. Homogenates were probed
with anti-DRPs antibodies. GAPDH reactivity
indicated equal total protein loading across the
lanes. Immunoblots showed no detectable DRPs
in NSC34 cells transfected with R0, R21, and R42
constructs.
(B) Cortical neurons were transfected with the
indicated constructs. Immunofluorescence anal-
ysis suggested that DRPs did not form in neurons
transfected with R42 constructs. Nuclei were
stained with DAPI (blue), green represents GFP-
DRPs, red represents Td-Tomato, which was co-
transfected with GFP-DRP constructs, and white
represents the respective DRPs. Calibration bar
represents 20 mm.
(C) Primary cortical neurons were transfected with
R0, R21, or R42 constructs and collected 72 hr
posttransfection. NSC34 cells transfected with
DRP constructs were used as positive controls.
Equal amounts of protein were loaded and actin
was used as a loading control. Dot blot analysis
suggests that no DRPs were generated from
cortical neurons expressing R0, R21, and R42.
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fibrillarin, another protein constituent of nucleolus (Ochs et al.,
1985), confirming their nucleolar partition (Figures S6C and
S6D). Similar aggregation in nucleoli was seen for GR50, even
though a good portion of them were still retained in the cytosol
(Figure S6E). We observed that neurons with nuclear PR aggre-
gates had a consistent reduction in the number of cytosolic
P-bodies (Figure 4E), which featured larger size on average (Fig-
ure 4F), and formed stress granules (Figure 4G).
Knockdown of C9ORF72 Does Not Affect Neuronal
Survival In Vitro
Studies of familial C9 patients have reported an approximately
50% reduction in C9ORF72 mRNA levels (DeJesus-Hernandez
et al., 2011; Renton et al., 2011), hypermethylation of these re-
peats and the neighboring CpG islands (Xi et al., 2013), suggest-
ing haploinsufficiency as the possible initiating mechanism of
neurodegeneration.
To test whether C9ORF72 is critical for neuronal survival, we
characterized an shRNA-GFP construct to efficiently knock
down C9ORF72 in cortical and motor neurons. This approach
also allowed the optimization of a commercially available anti-Neuron 84, 1213–1225, DeC9ORF72 antibody. The antibody de-
tected C9ORF72 isoform a and b (Wool-
lacott and Mead, 2014) when their
respective Flag-C9ORF72 cDNAs were
transfected in HEK293 cells (Figure 5A).
The antibody also detected endogenous
C9ORF72a but not C9ORF72b isoform
(Figure 5A). This antibody was then
used to confirm specific knockdown ofC9ORF72a with the shRNA construct (Figure 5B). Because the
shRNA sequence targets both C9ORF72 isoforms, the success-
ful knockdown of the endogenous isoform a (R70%) can imply a
similar outcome for isoform b. The fact that the antibody could
not detect endogenous C9ORF72b, despite the fact that the
antibody was recognizing both overexpressed isoforms with
similar affinity, suggests that C9ORF72a is the dominant isoform
(Figure 5A). When we used this antibody to probe the expression
levels of C9ORF72 in human lymphoblast lines derived from C9-
ALS/FTD patients, we found that expression levels of C9ORF72a
was decreased by 50% compared to controls (Figure 5C).
The sequence targeted by our shRNA construct is conserved
among human, mouse, and rat, so we could efficiently knock
down C9ORF72 in primary cortical neurons as well. Immunocy-
tochemistry analysis of NSC34 cells transfected with C9ORF72
cDNA tagged with Flag and Myc sequences showed prevalent
cytosolic staining of C9ORF72 (Figure 5D). The cytosolic locali-
zation of C9ORF72 was further confirmed by immunocytochem-
istry analysis of cortical neurons transfected with C9ORF72-
shRNA construct (Figure 5E).
To address whether downregulation of C9ORF72 expression
would lead to neuronal death, we transfected primary rat corticalcember 17, 2014 ª2014 Elsevier Inc. 1217
Figure 4. PR50 Nuclear Aggregates Colocalize with Nucleolin and
Mediate Cellular Stress Responses
(A) Cortical neurons transfected with a combination of R42 and PR50 con-
structs (0.4 mg R42 + 0.4 mg PR50 + 0.2 mg Td-tomato; total 1 mg/well cDNA)
displayed significant increase in cumulative risk of death compared to the
other three possible combinations, suggesting that R42 and PR50 increased
neural toxicity synergistically. The cDNA concentration for each toxic species
is 50% of the concentration used when R42 or PR50 were transfected alone in
other experiments. At least 80 neurons were imaged/group; n = 3 experiments.
**p < 0.01; ***p < 0.001.
(B) The combination of GA50 and R42 did not have synergistic effects. p = 0.08.
Data are shown as mean ± SEM.
(C and D) Immunofluorescence analysis of cortical neurons transfected with
PR50 revealed that PR50 nuclear aggregates colocalized with nucleolin in the
nucleolus (bottom) (C), and PR50 aggregates induced (D) dispersal of nucleolin
with increase innucleolus size.DAPI, blue;GFPcontrol orPR50, green;Nucleolin,
red.Calibrationbar represents10mm.**p<0.01.Dataareshownasmean±SEM.
(E) Neurons transfected with PR50 showed decreased number and increased
size of P-bodies. Representative images of GFP control or PR50-transfected
cortical neurons. DAPI, blue; Dcp1, white; GFP control or PR50, green. DCP1 is
the mRNA-decapping enzyme 1A, constituent of P-bodies. Calibration bar
represents 10 mm.
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1218 Neuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Incneurons with C9ORF72 shRNA-EGFP or scrambled shRNA con-
structs as control. Cortical neurons were cotransfected with the
synapsin promoter-driven Td-Tomato reporter construct for live-
cell imaging. Survival curves of cortical neurons treated with
shRNA or control scrambled shRNA were not statistically
different (Figure 5F). Similarly, C9ORF72 knockdown did not
affect survival of rat primary motor neurons (Figure 5G), indi-
cating that C9ORF72 loss of function is not a primary cause of
neurotoxicity in C9-ALS/FTD.
Ectopic Expression of C9RAN-Translated PR50
Dipeptide Leads to Neurodegeneration in Drosophila
melanogaster
An in vivo model was recently developed to investigate the
toxicity of expanded hexanucleotide transcripts. These tran-
scripts caused progressive neurodegeneration in the eye and
motor neurons of Drosophila (Xu et al., 2013). We wanted to
investigate whether C9RAN PR dipeptides could also lead to a
neurodegenerative phenotype in vivo and, therefore, generated
transgenic flies overexpressing flag-EGFP-tagged PR50. We
also generated transgenic flies expressing GA50 and PA50
because, despite theseDRPs lack in vitro toxicity, they displayed
quite distinctive localization patterns, which could possibly result
in a neurotoxic profile in vivo. These transgenes were inserted by
PhiC31 integration at the exact same genomic locus and are
therefore transcribed equally.
We found that targeted expression of PR50 caused severe
neurodegeneration in Drosophila eyes (Figure 6A). PR50 expres-
sion was not detectable by western blot analysis of the eye in
PR50 flies, presumably due to massive loss of the eye neurons.
Expression of mRNA of the DRP transgenes was verified in the
prepupae stage and found to be statistically not different among
the different fly lines, suggesting that the toxicity was not to be
ascribed to difference in DRP expression levels (Figure 6B). On
quantitation of the eye phenotype using our previously published
criteria (Lanson et al., 2011; Pandey et al., 2007), the ommatidia
appeared to be completely degenerated in flies ectopically ex-
pressing PR50, with loss of mechanosensory bristles and loss
of pigmentation, whereas expression of GA50, PA50, or flag-
EGFP control resulted in no obvious external eye degeneration
(Figures 6A and 6C).
In order to understand the consequences of PR50 in the motor
system, we targeted the expression of these poly-peptides to
motor neurons using the OK371-GAL4 driver. Contrary to the
other genotypes or control, PR50 expressors did not develop to
adulthood (Figure 6D). They fully developed to the pupal stage
and appeared morphologically normal, but we found that they
were unable to escape out of the pupal case, whereas flies(F) Quantification of number and size of P-bodies in control and PR50-trans-
fected cortical neurons displaying diffused and aggregated PR50. Diffused PR
staining was previously associated to neuronal survival. At least 20 neurons/
groupwere counted per experiment; n = 3. (***p < 0.001; two-tailed t test). Data
are shown as mean ± SEM.
(G) Stress granules formed only in motor neurons in which PR50 aggregated
(arrow). DAPI, blue; TIAR, red; GFP control or PR50, green; MAP-2, white. TIAR,
cytotoxic granule-associated RNA binding protein-like 1 (TIA1). Calibration bar
represents 10 mm.
.
Figure 5. C9ORF72 Knockdown in Primary Cortical and Motor Neu-
rons Does Not Cause Cell Death
(A) Characterization of C9ORF72 antibody and cytosolic localization of
C9ORF72. Immunoblotting shows that the C9ORF72 antibody recognizes
Flag-tagged C9ORF72 isoforms a and b transiently expressed in NSC34 cells;
for schematics of C9ORF72 isoforms a and b, seeWoollacott andMead (2014).
(B) C9ORF72 isoform a is efficiently knocked down in NSC34 cells. GAPDH
levels demonstrated equal protein loading in the control and C9ORF72
knockdown (C9-KD) lane.
(C) C9ORF72 protein levels are reduced in lymphoblasts of C9ORF72 ALS
patients. **p < 0.01; two-tailed t test. Data are shown as mean ± SEM.
(D) C9ORF72 isoforms a and b, Myc tagged, were transfected in NCS34 cells.
Double-label immunofluorescence shows cytosolic localization of transfected
C9ORF72a andC9ORF72b. Blue signals represent DAPI, red signals represent
C9ORF72 (antibody Sigma HPA023873), which recognized both isoforms, and
green represents Myc staining. Calibration bar represents 10 mm.
(E) Immunocytochemistry of C9ORF72 protein in cortical neurons transfected
with C9ORF72 shRNA construct GFP tagged. Nuclei are stained in blue (DAPI),
green signals represent GFP,which is coexpressedwithC9ORF72 shRNA, and
white signals represent C9ORF72 protein. Calibration bar represents 25 mm.
(F) Kaplan-Meier survival analysis of cortical neurons cotransfected with
C9ORF72 shRNA or scrambled shRNA and Td-tomato constructs (4:1 ratio)
shows that knockdown of C9ORF72 does not directly cause cell death in
primary cortical neurons. p = 0.312.
(G) Similarly, motor neuron survival was not affected by C9ORF72 knockdown.
p = 0.444.
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Neexpressing GA50, PA50, and control construct were able to
escape normally. These PR50-expressing flies had nomovement
and did not survive. Dissecting the PR50-expressing flies from
their pupal case, we found that these flies had no obvious de-
fects other than what could be expected from being paralyzed
with folded wings and legs, wet appearance and no movement
(Figure 6E). Similarly to the eye expressor line, PR50 could not
be detected by western blot analysis presumably due tomassive
loss of motor neurons. We, therefore, verified expression of the
DRP transgenes by qPCR at the larvae stage of the transgenic
flies and found that there was statistically no difference in the
DRP mRNAs in the different lines (Figure 6F). Furthermore, we
drove expression in muscles using MHC-GAL4 driver and
confirmed effective expression and similar expression levels of
the different C9RAN peptides by western blot analysis, with
GA50 dipeptides often found in the stacking gel (Figure 6G). To
confirm the subcellular localization pattern of the DRPs, we
used anti-lamin antibody to stain the nuclear envelope in the
Drosophila larvae neural tissue. Thus, staining inside the lamin
ring is nuclear and outside the ring is cytoplasmic (Daigle et al.,
2013; Lanson et al., 2011). We found that GA50 concentrated
in perinuclear or cytosolic aggregates, while PA50 and GFP
control displayed diffuse cytosolic localization. Similarly to
cultured neurons, PR50 was predominantly aggregated in nuclei
(Figure 6H).
PR Aggregates Are Toxic to Human iPSC-Derived
Neurons and Are Present in C9ORF72 ALS
Patient-Derived Human Induced Motor Neurons
and Postmortem Spinal Cord Tissues
To establish whether expression of PR was also toxic to human
neurons, we transfected human iPSC-derived generic neurons
with PR50, GA50, or control constructs. Transfection efficiency
of the constructs in these neurons was somewhat lower than
the one we achieved for rat primary neurons. Nevertheless, we
were able to build Kaplan-Meier survival curves and hazard anal-
ysis for each experimental group and found that PR50 was
potently toxic, whereas neurons expressing GA50 at similar
levels had a cumulative risk of death nonsignificantly different
from the control transfected group (Figure 7A). Similarly to
what was reported for rat primary neurons, we found PR50 aggre-
gates colocalized with nucleolin in nucleoli (Figure 7B). To deter-
mine whether PR aggregates are relevant to the human disease
state, we determined whether PR nuclear aggregates were also
endogenously expressed by induced motor neurons from
C9ORF72 ALS patients. We used transcription factor-mediated
lineage conversion (Son et al., 2011) to generate induced motor
neurons (iMNs) from iPSCs of C9ORF72 ALS patient and unaf-
fected control. In both patient and control cultures, we observed
cells with mature neuronal morphologies that expressed Hb9
and TuJ1, confirming their motor neuron identity (Figure 7C).
The iMNs were labeled with an Hb9::Channelrhodopsin-YFP re-
porter lentivirus (Marchetto et al., 2008). In control iMN cultures,
we rarely observed intranuclear PR+ aggregates, suggesting a
low level of PR production in these cells. Similarly, we observed
intranuclear PR+ aggregates in C9-ALS iMNs (Figure 7D). How-
ever, in contrast to control cultures, C9-ALS cultures contained
a high number of extracellular PR+ aggregates, and significantlyuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc. 1219
Figure 6. PR50 Expression Is Neurotoxic inDrosophila melanogaster
(A) Expression of C9ORF72 RAN proteins in Drosophila eyes. PR50 expression
causes complete degeneration of the eyes.
(B) mRNA of the DRPs was measured in the eyes of the different fly lines by
qPCR analysis (ANOVA; Kruskal-Wallis test; p = 0.4373). A wild-type, non-
transgenic fly strain (w1118) was crossed with the GMR-GAL4 strain to rule out
nonspecific qPCR amplification reactions of the different DRP50 mRNAs. Data
are shown as mean ± SEM.
(C) Quantification of eye phenotypes. PR50 expression produces a significant
toxic effect relative to the other RAN products and the control (**p < 0.001;
one-way ANOVA). Data are shown as mean ± SEM.
(D) PR50 expressors do not develop successfully to adulthood. Viability of F1
flies that express RAN proteins is measured relative to viability of F1 flies that
carry the TM6b balancer chromosome, which are produced in the same cross.
Data are shown as mean ± SEM.
(E) Flies that express PR50 in motor neurons are morphologically normal
despite being trapped in the pupal case. The pupal case of the trapped PR50
expressor has been removed for this picture. The folded wings and legs are
characteristic of the pupal state.
(F) Expression of C9RAN dipeptide mRNAs is equally expressed in OK371-
GAL4 motor neuron expressor Drosophila larvae (ANOVA; Kruskal-Wallis test;
p = 0.1251). Data are shown as mean ± SEM.
(G) Western blot showing expression of C9ORF72 RAN proteins in Drosophila
muscle tissue.
(H) Subcellular localization of GFP-tagged C9ORF72 RAN proteins in motor
neurons of Drosophila larvae. Lamin staining delineates the nuclear envelope.
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1220 Neuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Incfewer iMNs survived in C9-ALS cultures after extended periods,
indicating that they undergo accelerated neurodegeneration
relative to control iMNs (Figures 7E and 7F). Interestingly, we
also detected extracellular PR aggregates in primary cortical
and motor neuron cultures transfected with PR-expressing con-
structs. Live-cell imaging showed that PR aggregates remained
attached on the bottom of the dish once the PR-expressing neu-
rons (either motor or cortical neurons) lost membrane integrity
and died (Figures 1C, S4A, and S7). Overall, these results
demonstrate that human C9-ALS-derived motor neurons pro-
duce elevated levels of PR. Moreover, the presence of large
numbers of extracellular PR+ aggregates and reduced numbers
of iMNs in C9-ALS patient cultures agree with results in rodent
cultures.
Confocal microscopy analysis of spinal cord tissues from C9-
ALS and C9-ALS/FTD patients revealed the presence of PR+ nu-
clear as well as extranuclear inclusions (Figure 8A). Notably, PR+
aggregates were rarely detected in control nondiseased spinal
cords and, even less, in non-C9 spinal cords (Figures 8B and
S8C). In PR+ nuclei, poly-PR either aggregated in a relatively
large nuclear area or they formed punctate aggregates that co-
localized with nucleophosmin in nucleoli (Figures 8C and S8D).
Nuclei-containing PR aggregates often appeared smaller and
shaped irregularly compared to the well-rounded nuclei of the
control tissue, suggesting nuclear stress (Figure 8A).
DISCUSSION
Pathological findings in cells and tissues of C9ORF72-linked
ALS/FTD patients suggest three possible pathogenic mecha-
nisms of disease. The presence of RNA foci and accumulation
of RAN-translated proteins suggests an RNA-gain of function
or an RAN translation-induced toxicity. The evidence that cells
derived from C9ORF72 patients have decreased levels of
C9ORF72 transcripts suggests instead a loss-of-function mech-
anism. Increasing lines of evidence point at RNA gain of function
and RAN translation as the most likely mechanisms (Donnelly
et al., 2013; Gendron et al., 2013b; Haeusler et al., 2014; Zu
et al., 2013). However, whether one mechanism predominates
over the other or whether they both contribute to neurodegener-
ation is not clear. Similarly, it remains unknownwhether there are
neuronal-specific RAN toxic species. Recent studies showed
that arginine-rich RAN dipeptides were cytotoxic by impairing
the biogenesis of ribosomal RNA when nonneuronal cells (i.e.,
astrocytes and immortalized cell lines) were incubated with the
synthetic peptides (Kwon et al., 2014). Toxicity of these argi-
nine-rich peptides was also shown in vivo, in Drosophilamodels
(Mizielinska and Isaacs, 2014). Another study showed, instead,
that a different RAN-translated species, poly-GA, caused toxicity
measured by increased release of LDH, caspase-3 activation,
and endoplasmic reticulum stress when expressed in cultured
cells and primary neurons (Zhang et al., 2014).
Here, we extended these findings by employing a systematic
approach to determine the specific contribution to neurotoxicity
of each of the three C9ORF72-related pathological instances us-
ing disease-relevant human and rat neuronal cultures coupled to
longitudinal live-cell tracking imaging, as well as Drosophila
models. We provided clear evidence that: (1) among all the.
Figure 7. PR Aggregates Are Toxic to Hu-
man iPSC-Derived Neurons and Form in
iPSC-Derived Induced Motor Neurons from
C9ORF72 ALS Patients
(A) Cumulative risk of death analysis of iPSCs-
derived neurons transfected with GA50, PR50 or
control plasmid. Expression of PR50 significantly
increases the risk of death compared to that of
neurons expressing either GA50 or EGFP control.
At least 45 neurons were followed/group; n = 4
experiments; ***p < 0.001.
(B) Immunofluorescence analysis shows that PR
nuclear aggregates colocalize with nucleolin in
iPSC-derived neurons transfected with PR50
(bottom). DAPI, blue; PR50, green; Nucleolin, red;
TU-20, magenta. Calibration bar represents
10 mm.
(C) Characterization of iMNs. iMNs express HB9
and Tuj1. Hoechst, blue; HB9, green; Tuj1,
magenta. Calibration bar represents 10 mm.
(D) Immunofluorescence of PR aggregates in
control iMNs (top) and C9ORF72 ALS iMNs (bot-
tom). iMNs are labeled with Hb9::ChR87-YFP.
Arrowheads indicate intranuclear aggregates, and
arrows indicate extracellular aggregates. Hoechst,
blue; Hb9::ChR87-YFP, green; PR, red. Calibra-
tion bar represents 10 mm.
(E) Kaplan-Meier survival analysis of iMNs gener-
ated from two C9-ALS patients compared to two
control lines showed a significant iMN loss in C9-
ALS patient lines. ***p < 0.001.
(F) Significantly more extracellular PR aggregates
were observed in C9-ALS iMNs compared to
control iMNs. ***p < 0.001. Two control lines and
two patient lines were generated; 20 random fields
were analyzed per group. Data are shown as
mean ± SEM.
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Toxicity of C9RAN Peptides and G4C2 Transcriptspossible C9RAN-translated dipeptides, the arginine-rich anti-
sense transcript-encoded PR, and the sense transcript-encoded
GR are the neurotoxic species, with GR, but not PR, showing a
repeat length-dependent toxicity, whereas PR full toxicity was
already manifested at the lowest repeat length tested; (2) argi-
nine-rich C9RAN dipeptide toxicity follows their nuclear aggre-
gation; (3) the arginine-rich dipeptides aggregate in nucleoli,
causing a stress-response in cells, with a reduction in the number
of processing bodies and formation of stress granules; (4) intronic
G4C2 transcripts, but not loss of C9ORF72, are also toxic to mo-
tor and cortical neurons; (5) G4C2 neurotoxicity is independent
from the appearance of RAN pathology, although the neurotoxic
effects of intronic G4C2 transcripts synergize with that of PR ag-
gregates. Finally, we demonstrated that the equal sensitivity of
cortical and motor neurons to C9ORF72 is mutation specific.Neuron 84, 1213–1225, DeThe initiation of RAN translation is
thought to depend on RNA hairpin struc-
tures that utilize GC pairing (Zu et al.,
2011). A recent study demonstrated that
an RNA sequence of 38-G4C2 repeats
is sufficient to initiate this unconventional
translation in a cell line (Mori et al., 2013).
In the time frame of our experiments, wedid not detect C9RAN DRPs in neurons expressing R42 tran-
scripts, albeit the 42-G4C2 hexanucleotide repeats were prop-
erly expressed. This lack of RAN translation and DRP pathology
suggested that RAN translation might require selective, still un-
known, stressors to occur and provided us a suitable in vitro
model to test the neurotoxic profile of G4C2 transcripts and
DRPs independently from one another.
Intronic G4C2 transcripts and PR dipeptides are both suffi-
cient to induce death of both cortical and motor neurons in a
dose-dependent manner. However, subtoxic or threshold toxic
concentrations of R42 transcripts and PR dipeptides exhibit
neurotoxic synergy when coexpressed in the same neurons.
This opens up the possibility that C9ORF72 products, being G-
quartets formed from sense C9 transcripts (Haeusler et al.,
2014) or RAN-translated PR dipeptides formed from antisensecember 17, 2014 ª2014 Elsevier Inc. 1221
Figure 8. Nuclear PR Inclusions Are Found
in C9ORF72 ALS Patient Spinal Cord Tis-
sues
(A) Representative images of a 15-slice z series
performed on age-matched human lumbar spinal
cord slices from various patient types (control,
C9ORF72 mutation-negative ALS, and C9ORF72
mutation-positive ALS). PR dipeptides (green),
DAPI (blue), and merged images show absent to
low-intensity staining in control and C9ORF72
mutation-negative ALS tissues. C9ORF72 muta-
tion-positive tissues show higher intensity staining
aswell as nuclear localization of the PR dipeptides.
(B) Quantification of PR-positive nuclei was per-
formed on 20 15-slice z series images for each
patient typewith400 nuclei quantified.C9ORF72
mutation positive tissues showed a significantly
higher (p < 0.0001) percent of PR-positive nuclei
(18.96 ± 1.07) than control (4.464 ± 0.88) and
C9ORF72 mutation-negative ALS (2.44 ± 0.67).
Data are shown as mean ± SEM.
(C) Immunofluorescence analysis shows that PR
aggregates colocalize with nucleophosmin (NPM)
in the nucleus from C9ORF72 mutation-positive
patient spinal cord tissues. DAPI, blue; PR, green;
NPM, red. Calibration bar represents 5 mm.
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More studies are needed to tease out the many possible toxic
combinations that could originate from C9 transcripts and,
more importantly, to determine what triggers them. Of the five
possible C9RAN dipeptides tested, only the arginine-rich PR
and GR were neurotoxic. They were also the only two DRPs
with a nuclear localization profile. In particular, the risk of death
of neurons expressing PR considerably increased if nuclear ag-
gregates were present. PR nuclear aggregation was confirmed
both in human induced motor neurons derived from iPSCs and
in postmortem spinal cord tissue of C9-ALS patients. Moreover,
aggressive toxicity and nuclear aggregation phenotype were
also seen in human iPSC-derived neurons from nondiseased in-
dividual transfected with PR50 and in vivo in a Drosophilamodel.
Thus, our data suggested that the arginine-rich poly-peptides1222 Neuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc.are the key toxic C9RAN products in
C9-ALS/FTD. Live-cell imaging analysis
showed that PR aggregates are stable
and persist in the dish long after the
neuron has died. Interestingly, we
observed that in induced motor neuron
cultures derived from C9 patients, there
was an increased number of extracellular
PR aggregates in the dish, which paral-
leled increased cell loss relative to control
cultures, suggesting that PR-bearing C9
patient neurons did not survive in culture
and the cells underwent a selection pro-
cess. In line with recently reported histo-
pathological analysis of DRP formation
in postmortem CNS tissues of C9-ALS/
FTD patients, our risk of death analysisunderscores PR strong neurotoxic potential and predicts that
only evidence of nontoxic DRP formation may be preponderant
in the postmortem tissue. It is, therefore, not surprising that PR
aggregates have been seldom found in postmortem disease-
affected tissue of C9 patients. On the other hand, GA, GR, PA,
and GP inclusions, which are mild or not neurotoxic in our as-
says, have been found throughout different CNS areas, including
those not affected by disease (Gendron et al., 2013a, 2013b; Zu
et al., 2013). Nonetheless, we provided here clear evidence for
PR nuclear aggregates, including instances of nucleolar localiza-
tion, in spinal cord tissues of C9-ALS patients. Similarly, Picker-
ing-Brown and colleagues found evidence of PR proteins that
displayed strong immunoreactivity of chromatin in pyramidal
cells of the hippocampus, suggesting nuclear localization of
the PR polypeptides (Mann et al., 2013). Whether PR
Neuron
Toxicity of C9RAN Peptides and G4C2 Transcriptsaggregation is cell type specific in the human disease context re-
mains to be further examined.
Our studies differentiated the possible role of RAN dipeptides
in disease. While GA, GR, PA, and GP could represent patholog-
ical hallmarks detectable in surviving neurons, PR is the patho-
genic candidate whose presence predisposes neurons to
quickly degenerate and die. For disease-relevant mechanisms,
the predictive nature of our culture assay is also validated by
the cell and mutation specificity of our findings. Hippocampal
neurons, which are seemingly less affected in C9-FTD and C9-
ALS/FTD, are also significantly less sensitive to PR toxicity in cul-
tures. Resilience to PR and/or R42 toxicity in cells not affected by
disease and the mutant-specific vulnerability of different
neuronal types implied the occurrence of molecular pathways
capable of defining disease phenotypes. The message that
different cells respond differently to the same toxic insults and
that pathological markers do not necessarily correlate with dis-
ease pathogenesis underscores the importance of dissecting
disease mechanisms, even in relatively simple systems. The
knowledge could be critical when identifying relevant and spe-
cific therapeutic targets.
But the most pressing question for the development of thera-
pies aimed at stopping or even preventing neurotoxicity is how
PR or, more in general, arginine-rich expanded poly-dipeptides
give rise to neurodegeneration. Different groups have reported
evidence for alterations in translational control of gene expres-
sion, characterized by alterations in P-bodies and appearance
of stress granules (SGs) in cell models of neurodegenerative dis-
ease (Nonhoff et al., 2007; Savas et al., 2008). In this respect, an
interesting parallel can be drawn with the neurotoxicity of PR di-
peptides. In neurons with nuclear PR aggregates, we found a
significant reduction in the number of P-bodies concomitant to
increased size average and the appearance of SGs. These
RNA granules are silencing foci as they typically harbor tran-
scripts circumstantially excluded from the translationally active
pool (Thomas et al., 2011). P-bodies are constitutive but respond
to stimuli that affect mRNA translation and decay. SGs are spe-
cifically induced upon cellular stress, which triggers a global
translational silencing of several pathways. Various changes in
cell physiology are able to affect these RNA granules in size
and numbers. At this point of our investigation, however, it is
not possible to establish a firm temporal sequence of events
leading to neurodegeneration as there is not enough functional
data to support dysregulation of RNA granules as the leading
mechanism of PR aggregate toxicity.
Interestingly, P-body dysregulation may result from nucleolar
stress (Kedersha et al., 2008). We found that PR aggregates
aberrantly accumulate in the nucleolus, which appears enlarged.
Nucleoli control ribosome biogenesis and protein trafficking un-
der cellular stress (Nalabothula et al., 2010). Thus, in the case of
PR-containing neurons, where the nucleolus is enlarged and the
number of P-bodies reduced, it is tempting to hypothesize PR-
induced nucleolar stress as the mechanism that marks neurons
destined to degenerate. Similarly to what we found here for PR-
mediated neurotoxicity, Wang and colleagues have recently pro-
posed nucleolar stress followed by alterations in P-bodies as
possible mechanism(s) for G4C2 hexanucleotide repeat expan-
sions toxicity (Haeusler et al., 2014). Additionally, the synergisticNeneurotoxic effect between R42 transcripts and PR dipeptides
points at nucleolar stress as a converging mechanism between
these two toxic insults.
Overall, the data presented here support a gain-of-function
mechanism of C9ORF72-ALS/FTD toxicity and identify relevant
toxic species in this gain-of-function pathway(s). Loss of
C9ORF72 function achieved by knockdown approach did not
impact survival of both cortical and motor neurons, suggesting
that loss of C9ORF72 function may not be one mechanism con-
tributing to neurodegeneration. However, we do not know what
could be the impact on neurons of knocking down C9ORF72
over the timescale of the human lifetime. Therefore, we cannot
exclude for sure the loss-of-function hypothesis as one mecha-
nism contributing to neurodegeneration in C9-ALS/FTD.
The identification of C9ORF72-linked toxic species could
allow for the design of targeted therapeutics that are specifically
tailored toward disrupting their formation rather than affecting
the downstream cascade of events. In particular, this would
reduce the risk for unwanted side effects. Since DRP toxicity
seems dependent on PR nuclear accumulation, perhaps an
approach aimed selectively at preventing or breaking these nu-
clear aggregates would be more likely to succeed.
EXPERIMENTAL PROCEDURES
Primary Neuronal Cultures and Transfections
Primary cortical/hippocampal neurons were prepared from embyronic day 19
(E19) rat embryos as previously described (Kayser et al., 2006). Cortical neu-
rons were plated at a density of 90,000/well on poly-D-lysine- and laminin-
coated 24-well plates or 12 mm coverslips. Hippocampal neurons were plated
at a density of 25,000/well on poly-D-lysine- and laminin-coated 24-well plates
or 12 mm coverslips. We added 5 mM Ara-C 3 days after plating to inhibit pro-
liferation of dividing cells. Purified primary motor neurons were prepared from
E14.5 rat embryos as previously described (Magrane´ et al., 2012). Motor neu-
rons were plated at a density of 15,000/well on poly-D,L-ornithine- and lami-
nin-coated 24-well plates or coverslips. Cortical/hippocampal neurons were
transfected using Lipofectamine 2000 at DIV10 (1 mg of total DNA/well), while
motor neurons at DIV5–DIV7 (0.5 mg of total DNA/well). Synapsin-driven
Td-Tomato reporter construct was cotransfected in cortical/hippocampal
neurons and motor neurons with C9-related cDNA constructs at a ratio of 1:4.
Immunocytochemistry and Confocal Microscopy
Primary neuronal cultures were fixed in 3.6% PFA in PBS for 10 min at room
temperature. Neurons were then permealized in 0.25% PBST for 15 min at
room temperature and blocked in 1% BSA in PBST for 1 hr at room tempera-
ture, incubated with primary antibodies at 4C overnight, secondary anti-
bodies at room temperature for 1 hr, and mounted with anti-DAPI prolong-
gold anti-fade mounting media (Invitrogen). Neurons were washed with PBS
three times between each step. The following primary antibodies were used:
a-C9ORF72 (Sigma HPA023873, 1:200), a-Myc (Cell Signaling 2276,
1:1,000), a-TIAR (BD Transduction Laboratories 610352, 1:250), a-DCP1A
(Sigma D5444, 1:500), a-Nucleolin (ProteinTech 10556-1-AP, 1:2,000),
a-SMI32 (Covance SMI-32R, 1:1,000), a-MAP2 (Millipore AB5622, 1:500),
a-Fibrillarin (SantaCruz sc-25397, 1:200), a-TU20 (Abcam ab7751 1:500),
a-HB9 (DSHB 81.5C10, 1:5), a-Tuj1 (Millipore AB9354, 1:1,000), and a-PR
(ProteinTech 23979-1-AP, 1:1,000). Cells were imaged using confocal micro-
scopy (Olympus FV1000). We acquired six to ten images at a 0.3-mm-step size
and projected onto one single image.
Longitudinal Live-Cell Imaging Analysis
For longitudinal live-cell imaging and neuronal survival analysis, we used an
automated imaging system consisting of an inverted Nikon Eclipse Ti micro-
scope equipped with PerfectFocus, a Tokai Hit stage top incubator with gasuron 84, 1213–1225, December 17, 2014 ª2014 Elsevier Inc. 1223
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Toxicity of C9RAN Peptides and G4C2 Transcriptsand temperature controller, and a CoolSNAP ES2 high-performance CCD
camera.
Quantification of Nucleoli and Processing Bodies
The number and size of P-bodies and nucleoli size were quantifiedwith ImageJ
software (NIH) using a manual and an automatic method. The manual method
is based on the Cell Counter plugin to mark individual P-bodies by hand. P-
bodies were counted based on size of fluorescence. The automatic method
relied on an unbiased approach using a computational algorithm built in.
Confocal images showing fluorescence of the soma and P-bodies were con-
verted to 16-bit grayscale and the soma was traced to create boundaries for
the analysis. Threshold of the image was then adjusted to highlight P-bodies
and the background was subtracted to split overlapping P-bodies. The P-
bodies were then analyzed using the Analyze Particles plugin with a minimum
pixel size of 2. The average size of the P-bodies was also retrieved through this
method. Overall, there was no significant difference between the manual and
automatic methods. Nucleoli size was quantified bymean of the nucleolin fluo-
rescence staining using the automatic method in the ImageJ software. The nu-
cleus for each cell was traced for the boundaries and the area of the nucleus
analyzed using the measure function. Using the same boundaries, the
threshold of the image was then adjusted to highlight nucleolin fluorescence
area and the background was subtracted. Nucleolin area was then analyzed
using the Analyze Particles plugin with a minimum pixel size of 2. The
measured nucleolin area was compared as a percentage of the nucleus area.
Fly Transgenesis and Experiments
Transgenic flies that carry GAL4-activatable genes encoding RAN proteins
were generated by the BestGene. Eye expression, motor neuron expression,
and muscle expression were induced by crossing C9RAN protein flies with
the GMR GAL4 strain (Bloomington Stock Center), the OK371 GAL4 strain
(Mahr and Aberle, 2006), and the MHC GAL4 strain at 25C, respectively.
Eye phenotype was scored and differences between the genotypes were as-
sessed using one-way ANOVA and Scheffe’s post hoc test. For the viability
assay, C9RAN protein flies containing the TM6b balancer were crossed with
OK371 GAL4 driver flies. Further details are provided in the Supplemental
Experimental Procedures.
Statistics
For survival analysis, death was defined by the time at which a neuron was last
imaged with intact neurites and no evidence of swollen soma or cell blebbing.
Kaplan-Meier survival and Cox proportional hazards analysis were carried out
using SPSS 19.0 software, while other statistical analysis was carried out using
GraphPadPrism 6. Differences in Kaplan-Meier curveswere assessedwith the
log-rank test. Comparisons between experimental groups in bar graphs were
done by one-way ANOVA or t test as indicated. Data are expressed as
average ± SEM. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and eight figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2014.12.010.
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